Cargando…

Debate: PCI vs CABG: a moving target, but we are gaining

The treatment of patients with coronary artery disease continues to evolve; all three strategies – medical therapy, surgical revascularization, and percutaneous coronary intervention – have changed. Medical therapy with intense risk-factor modification and treatment with a statin, aspirin, and angio...

Descripción completa

Detalles Bibliográficos
Autor principal:	Holmes, David R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64826/ https://www.ncbi.nlm.nih.gov/pubmed/11806810 http://dx.doi.org/10.1186/cvm-2-6-263

Ejemplares similares

Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
por: Bhatt, Deepak L, et al.
Publicado: (2001)

PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017)

Moving the debate forward: interculturalism’s contribution to multiculturalism
por: Boucher, François, et al.
Publicado: (2018)

Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
por: Eifert, Sandra, et al.
Publicado: (2010)

Evidence based decision making between PCI and CABG
por: Collet, Carlos
Publicado: (2019)

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
por: Persson, Jonas, et al.
Publicado: (2023)

Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery
por: Guo, Cheng-Long, et al.
Publicado: (2017)

Mammographic screening debate on study design: a need to move the field forward
por: Ursin, Giske
Publicado: (2012)

Commentary: Ticagrelor monotherapy—Not for CABG?
por: Sandner, Sigrid, et al.
Publicado: (2022)

CABG versus PCI: What is the optimal strategy for multi-vessel disease?
por: Kumar, Ayush, et al.
Publicado: (2022)

Debate: Unstable angina - When should we intervene?
por: Kereiakes, Dean J
Publicado: (2000)

Antiplatelet therapy with CABG: chaos in the Netherlands
por: Verheugt, F. W. A.
Publicado: (2017)

Impact of time factor and patient characteristics on the efficacy of PCI vs CABG for left main coronary disease: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Myocardial Revascularization in New York State: Variations in the PCI-to-CABG Ratio and Their Implications
por: Ko, Wilson, et al.
Publicado: (2012)

PCI versus CABG in patients with complex coronary artery disease: Time for reconciliation?
por: ElGuindy, Ahmed M, et al.
Publicado: (2013)

Comparing CABG and PCI across the globe based on current regional registry evidence
por: Caldonazo, Tulio, et al.
Publicado: (2022)

Meta-analysis of clinical adverse events after CABG vs. PCI in patients with chronic kidney disease and coronary artery disease
por: Luo, Cheng, et al.
Publicado: (2023)

Telemedicine in post–CABG patients: promises and pitfalls
por: Hofstra, L., et al.
Publicado: (2021)

Cardiac rehabilitation outcomes following a 6-week program of PCI and CABG Patients
por: Jelinek, Herbert F., et al.
Publicado: (2013)

Commentary: Are we wrapping up the debate on repair of giant paraesophageal hernia?
por: Pontula, Arya, et al.
Publicado: (2021)

Giant Intramural Right Ventricular Hematoma after PCI in a Patient with Condition after CABG
por: Vondran, Maximilian, et al.
Publicado: (2020)

Debate: When should we intervene in unstable angina - Time for an old look?
por: Laskey, Warren K
Publicado: (2000)

The Attentional Capture Debate: When Can We Avoid Salient Distractors and When Not?
por: Theeuwes, Jan
Publicado: (2023)

Ticagrelor monotherapy after CABG—Probably not at all and definitely not forever
por: Sandner, Sigrid, et al.
Publicado: (2022)

Debating the State-of-the-Art CTO PCI: Is There Still Room for Discussion?
por: Komiyama, Hidenori, et al.
Publicado: (2023)

Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis
por: Rozemeijer, Sander, et al.
Publicado: (2023)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

The Impact of the Risk Factors in the Evolution of the Patients with Left Main Coronary Artery Stenosis Treated with PCI or CABG
por: TRAȘCĂ, SP, et al.
Publicado: (2019)

Moving beyond the GM Debate
por: Leyser, Ottoline
Publicado: (2014)

Preoperative IABP in high risk patients undergoing CABG
por: Theologou, T, et al.
Publicado: (2011)

Moving from the terminology debate to a transdisciplinary understanding of the problem: Commentary on: Ten myths about work addiction (Griffiths et al., 2018)
por: Quinones, Cristina
Publicado: (2018)

Move from Traditional Histopathology to Digital and Computational Pathology: Are we Ready?
por: Mubarak, Muhammed
Publicado: (2022)

Long-Term Mortality of 306,868 Patients with Multi-Vessel Coronary Artery Disease: CABG versus PCI
por: Efird, Jimmy T., et al.
Publicado: (2013)

The Effect of Enhanced External Counterpulsation (EECP) on Quality of life in Patient with Coronary Artery Disease not Amenable to PCI or CABG
por: Jan, Rafiullah, et al.
Publicado: (2020)

Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry
por: Yamaji, Kyohei, et al.
Publicado: (2022)

The reproducibility debate is an opportunity, not a crisis
por: Munafò, Marcus R., et al.
Publicado: (2022)

Effects of a home based exercise intervention on cardiac biomarkers, liver enzymes, and cardiometabolic outcomes in CABG and PCI patients
por: Olgoye, Ashrafolsadat Mashhad, et al.
Publicado: (2021)

To sniff or not to sniff: The eternal debate
por: Sarma, Riniki, et al.
Publicado: (2020)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Temporal Pattern of CABG and PCI after Non-ST Elevation Myocardial Infarction Among Elderly Patients from NHDS
por: Siddiqui, Muhammad U, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5vgd3qjs70e6qria3h4qeu374g